Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.
about
Non-antibody protein-based biosensorsFluorescent imaging of cancerous tissues for targeted surgery.Hybrid integrated label-free chemical and biological sensorsLanthanide binding and IgG affinity construct: Potential applications in solution NMR, MRI, and luminescence microscopyFusion to a highly stable consensus albumin binding domain allows for tunable pharmacokineticsA current perspective on applications of macrocyclic-peptide-based high-affinity ligandsIntraoperative Fluorescence Imaging for Personalized Brain Tumor Resection: Current State and Future Directions.Emerging optical methods for surveillance of Barrett's oesophagusArtificial affinity proteins as ligands of immunoglobulinsLiposomes as nanomedical devicesUnderstanding FRET as a research tool for cellular studiesDifferences in X-chromosome transcriptional activity and cholesterol metabolism between placentae from swine breeds from Asian and Western originsInfluence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterpartsDesired alteration of protein affinities: competitive selection of protein variants using yeast signal transduction machineryExtremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein ScaffoldRESOLFT Nanoscopy of Fixed Cells Using a Z-Domain Based Fusion Protein for LabellingTargeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog FludarabineCellular effects of HER3-specific affibody moleculesDirected Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.Externally modulated theranostic nanoparticlesEngineering bispecificity into a single albumin-binding domain.Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cellsEngineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer CellsPET of HER2 Expression with a Novel 18FAl Labeled Affibody.Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.Delivery of mirror image polypeptides into cellsBacterial display in combinatorial protein engineering.Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabelingIn vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkersDetection of biomarkers using recombinant antibodies coupled to nanostructured platformsStaphylococcal display for combinatorial protein engineering of a head-to-tail affibody dimer binding the Alzheimer amyloid-β peptide.SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly.Surface display of a single-domain antibody library on Gram-positive bacteria.Peptide aptamers: development and applications.Folding and function in α/β-peptides: targets and therapeutic applications.An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion proteinEngineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imagingFluorescent affibody peptide penetration in glioma margin is superior to full antibody
P2860
Q26745879-73A683AC-251A-4E8B-8CCB-8E43A98FA061Q26830905-E44D549C-8D67-4F64-9C75-207C34EE443EQ27027536-365D19B4-2E47-4CC7-9E65-1463C1996136Q27671018-5A8F9F47-F45D-498B-8547-DB5557523C1BQ27701821-B9326109-A2D0-4586-BA78-9F87694B15C0Q28072407-257E27CA-E1D0-4432-B8C7-C1636F2C3F61Q28073893-8BA33051-CA54-4E17-8E1B-930AD4D6A873Q28082600-83F5BD65-D3C3-4BE8-8B8A-A6D3D107E6DFQ28083126-E3450467-746B-4CD6-9946-DE8BA9F800BBQ28088315-033E2FD6-BA24-499A-9FCE-EAD6BBD1495DQ28088633-AB235C14-6171-43B2-B477-2F4363F9A82CQ28284961-1CB3DB3B-0E83-490E-9770-9D71DA398CD4Q28535054-CF05BEE6-8969-4C3C-9128-0B43DE903B94Q28543140-8BCD5293-4D63-4B1B-9A9E-B23D5334D5C0Q28547051-66472206-D0B0-4227-88A7-5183F291C03CQ28548122-DA1D2EA9-2832-4423-AF86-CF6B0FA94F3EQ28550176-946C27D3-3060-44D1-9FDD-DBDC814B1BD5Q28727774-7B7B89B2-B8BD-4C35-8D9E-3CA8EDC89E16Q30009044-B30E9692-BD49-42AB-BD98-027C5CC68C08Q30382600-48125A78-EC62-424F-9C50-1B41E9A8CBA8Q30438597-AA2CAAAE-BD38-45B7-AD1C-FDED8809DD30Q31032588-CB2C83DF-8270-4964-9827-164B3F17B5ADQ31151707-CB83CCBF-71AE-4232-A922-8FC03D6D612EQ33691823-1CD65C5A-1195-4CD8-BD60-81831371922EQ33776692-A28DA7D3-F35F-4ECA-ACF5-68F53CD66EA1Q33777866-7601F51F-FD25-489A-B5DE-58DF743CF728Q33841547-7B3DEDFC-8203-4D52-9E97-273E6EF3A35FQ33856364-106868A6-5ECA-4751-875F-F731D29231DEQ33970172-1C842886-D2F4-4888-9CB7-9BA52B8F0AFBQ34148890-098A0013-D280-4CB7-BDB2-E0F7FD8F4C01Q34182033-660C836B-A74A-4200-A285-B68046DBF37FQ34352221-CCD16B9F-3098-4851-B712-E3BBD770BD52Q34417444-B267BA0B-0D75-459D-B762-6C3F9FAC295DQ34433158-D56AA945-F27B-4DE5-BBED-8646AD2B99BFQ34445095-870CFF95-9B83-4871-90AE-787D6B0DB18EQ34471346-E0DA2AA5-D042-4C1D-BE38-29DA99FAA6F1Q34483276-DF517B1C-830E-4C54-BCA7-AA2856316248Q34661388-00AC1FA3-7405-46C8-910A-5D3026F44FC8Q34662001-9DE49F1F-D875-4A73-A154-43FC6DDBFC4EQ34673086-B48E490B-29DB-4F12-810C-849CACD4D0B7
P2860
Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Affibody molecules: engineered ...... biotechnological applications.
@en
Affibody molecules: engineered ...... biotechnological applications.
@nl
type
label
Affibody molecules: engineered ...... biotechnological applications.
@en
Affibody molecules: engineered ...... biotechnological applications.
@nl
prefLabel
Affibody molecules: engineered ...... biotechnological applications.
@en
Affibody molecules: engineered ...... biotechnological applications.
@nl
P2093
P2860
P1433
P1476
Affibody molecules: engineered ...... biotechnological applications
@en
P2093
P2860
P304
P356
10.1016/J.FEBSLET.2010.04.014
P407
P577
2010-04-11T00:00:00Z